Seattle, WA, United States of America

Daniel-Adriano Silva

This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel-Adriano Silva. Retrieved from https://idiyas.com/inventor/daniel-adriano-silva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daniel-Adriano Silva

Introduction

Daniel-Adriano Silva is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for diseases related to the Epstein-Barr virus.

Latest Patents

One of his notable patents is titled "Polypeptides to inhibit Epstein Barr viral protein BHRF1 and B cell lymphoma family proteins." This invention provides designed polypeptides that selectively bind to and inhibit Epstein Barr protein BHRF1, as well as B cell lymphoma family proteins. These polypeptides are useful for treating Epstein Barr-related diseases and cancer.

Career Highlights

Daniel-Adriano Silva is affiliated with the University of Washington, where he continues to advance his research and innovation in the field of biotechnology. His work has the potential to impact the treatment of various cancers and viral infections.

Collaborations

He has collaborated with notable researchers such as Erik Procko and David Baker, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Daniel-Adriano Silva's work exemplifies the intersection of science and innovation, particularly in the fight against viral infections and cancer. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…